Exact Mass: 507.1965
Exact Mass Matches: 507.1965
Found 156 metabolites which its exact mass value is equals to given mass value 507.1965
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Tyr-Tyr-Tyr
(2E)-3-[2,3-dihydro-2-(4-hydroxy-3,5-dimethoxyphenyl)-3-(hydroxymethyl)-1,4-benzodioxin-6-yl]-N-[2-(4-hydroxyphenyl)ethyl]prop-2-enamide|thoreliamide B
Cys Glu Glu Lys
Cys Glu Lys Glu
Cys Lys Glu Glu
Asp Asp Lys Met
Asp Asp Met Lys
Asp Lys Asp Met
Asp Lys Met Asp
Asp Met Asp Lys
Asp Met Lys Asp
Asp Asn Pro Tyr
Asp Asn Tyr Pro
Asp Pro Asn Tyr
Asp Pro Tyr Asn
Asp Ser Thr Trp
Asp Ser Trp Thr
Asp Thr Ser Trp
Asp Thr Trp Ser
Asp Trp Ser Thr
Asp Trp Thr Ser
Asp Tyr Asn Pro
Asp Tyr Pro Asn
Glu Cys Glu Lys
Glu Cys Lys Glu
Glu Glu Cys Lys
Glu Glu Lys Cys
Glu Lys Cys Glu
Glu Lys Glu Cys
Glu Met Gln Thr
Glu Met Thr Gln
Glu Gln Met Thr
Glu Gln Thr Met
Glu Ser Ser Trp
Glu Ser Trp Ser
Glu Thr Met Gln
Glu Thr Gln Met
Glu Trp Ser Ser
Lys Cys Glu Glu
Lys Asp Asp Met
Lys Asp Met Asp
Lys Glu Cys Glu
Lys Glu Glu Cys
b-D-Glucopyranosiduronic acid, 4-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxyphenyl, (3S-tr
Lys Met Asp Asp
5-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxy-, (3S-trans)-Phenol glucuronide
Met Asp Asp Lys
Met Asp Lys Asp
Met Glu Gln Thr
Met Glu Thr Gln
Met Lys Asp Asp
Met Gln Glu Thr
Met Gln Thr Glu
Met Thr Glu Gln
Met Thr Gln Glu
Asn Asp Pro Tyr
Asn Asp Tyr Pro
Asn Pro Asp Tyr
Asn Pro Tyr Asp
Asn Tyr Asp Pro
Asn Tyr Pro Asp
Pro Asp Asn Tyr
Pro Asp Tyr Asn
Pro Asn Asp Tyr
Pro Asn Tyr Asp
Pro Tyr Asp Asn
Pro Tyr Asn Asp
Gln Glu Met Thr
Gln Glu Thr Met
Gln Met Glu Thr
Gln Met Thr Glu
Gln Thr Glu Met
Gln Thr Met Glu
Ser Asp Thr Trp
Ser Asp Trp Thr
Ser Glu Ser Trp
Ser Glu Trp Ser
Ser Ser Glu Trp
Ser Ser Trp Glu
Ser Thr Asp Trp
Ser Thr Trp Asp
Ser Trp Asp Thr
Ser Trp Glu Ser
Ser Trp Ser Glu
Ser Trp Thr Asp
Thr Asp Ser Trp
Thr Asp Trp Ser
Thr Glu Met Gln
Thr Glu Gln Met
Thr Met Glu Gln
Thr Met Gln Glu
Thr Gln Glu Met
Thr Gln Met Glu
Thr Ser Asp Trp
Thr Ser Trp Asp
Thr Trp Asp Ser
Thr Trp Ser Asp
Trp Asp Ser Thr
Trp Asp Thr Ser
Trp Glu Ser Ser
Trp Ser Asp Thr
Trp Ser Glu Ser
Trp Ser Ser Glu
Trp Ser Thr Asp
Trp Thr Asp Ser
Trp Thr Ser Asp
Tyr Asp Asn Pro
Tyr Asp Pro Asn
Tyr Asn Asp Pro
Tyr Asn Pro Asp
Tyr Pro Asp Asn
Tyr Pro Asn Asp
N-(4(4-PIPERIDINOMETHYL) PYRIDYL-2-OXY)-CIS-2-BUTENE)PHTALMIDE MALEATE
2-[(1E,3Z)-3-CYANO-5-(1,3,3-TRIMETHYL-1,3-DIHYDRO-2H-INDOL-2-YLIDENE)-1,3-PENTADIENYL]-1,3,3-TRIMETHYL-3H-INDOLIUM PERCHLORATE
EMA401
Olodanrigan (EMA401) is a highly selective, orally active, peripherally restricted angiotensin II type 2 receptor (AT2R) antagonist. It is under development as a neuropathic pain therapeutic agent. Olodanrigan (EMA401) analgesic action appears to involve inhibition of augmented AngII/AT2R induced p38 and p42/p44 MAPK activation, and hence inhibition of DRG neuron hyperexcitability and sprouting of DRG neurons[1][2][3][4].
1,3,5-tris[3-(pyridin-4-yl)-1H-pyrazol-1-yl]benzene
SRT 1460
SRT 1460, a potent Sirtuin-1 (SIRT1) activator with an EC1.5 value of 2.9 μM, shows good selectivity for activation of SIRT1 versus SIRT2 and SIRT3 (EC1.5>300 μM), and is more potent than Resveratrol and the closest sirtuin homologues[1].
2-[[[2-Amino-1-(3-methoxypropyl)-3-pyrrolo[3,2-b]quinoxalinyl]-oxomethyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid ethyl ester
N-alpha-(2-Naphthylsulfonyl)-N(3-amidino-L-phenylalaninyl)-4-acetyl-piperazine
(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)nonan-1-imine
(2R)-2-[[(2S)-2-[[(2R)-2-[(2R,3S,4R,5R,6S)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxypropanoyl]amino]propanoyl]amino]pentanedioic acid
(2R)-2-[[(2S)-2-[[(2R)-2-[(2R,3S,4R,5R,6R)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxypropanoyl]amino]propanoyl]amino]pentanedioic acid
(1R,2R,5S,8S,9S,10R,11R,12S)-5-hydroxy-11-methyl-6-methylidene-16-oxo-12-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadec-13-ene-9-carboxylate
(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2,3,4,7-tetrahydro-1,5-benzoxazonin-6-one
NTNCB (hydrochloride)
NTNCB (Compound 11) hydrochloride is a potent and selective neuropeptide Y Y5 (NPY Y5) receptor antagonist with a Ki of 8 nM against human Y5[1].
n-[(2r,3r,4r,6r)-6-{[(3s)-3-ethyl-6-hydroxy-1,7,12-trioxo-3,4-dihydro-2h-tetraphen-8-yl]oxy}-3-hydroxy-2-methyloxan-4-yl]ethanimidic acid
(12r,15s)-9-ethyl-4,18-dihydroxy-12-(1-hydroxyethyl)-3,15-dimethyl-13-oxa-19-azatetracyclo[18.3.1.0⁵,²³.0¹⁵,²¹]tetracosa-1(23),2,4,10,16,18,20-heptaene-6,14,22,24-tetrone
3'-hydroxy-n-demethylrocaglamide
{"Ingredient_id": "HBIN008730","Ingredient_name": "3'-hydroxy-n-demethylrocaglamide","Alias": "NA","Ingredient_formula": "C28H29NO8","Ingredient_Smile": "CNC(=O)C1C(C2(C(C1O)(C3=C(C=C(C=C3O2)OC)OC)O)C4=CC(=C(C=C4)OC)O)C5=CC=CC=C5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9980","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}